🔥🐔 BizChicken 🐔🔥

Companies Similar to Enveric Biosciences, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Berubicin

CNS Pharmaceuticals, Inc. is a clinical pharmaceutical company focused on developing anti-cancer drugs for brain and central nervous system tumors. Their lead drug candidate, Berubicin, targets glioblastoma multiforme through clinical trials and partnerships with notable institutions.

Tags: Anti-cancer drugs, Berubicin, Brain Tumors, CNS Tumors, Clinical Trials, Pharmaceuticals

Symbol: CNSP

Recent Price: $0.11

Industry: Biotechnology

CEO: Mr. John Michael Climaco Esq., J.D.

Sector: Healthcare

Employees: 3

Address: 2100 West Loop South, Houston, TX 77027

Phone: 800 946 9185

Last updated: 2024-12-31

Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc. logo
Market Cap: High
Employees: Lowest

small molecule kinase inhibitors

Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule inhibitors for cancer treatment, including key products ELVN-001 and ELVN-002 under clinical trials.

Tags: biopharmaceutical, cancer treatment, clinical-stage, kinase inhibitors, small molecule inhibitors

Symbol: ELVN

Recent Price: $22.39

Industry: Biotechnology

CEO: Mr. Samuel S. Kintz M.B.A.

Sector: Healthcare

Employees: 52

Address: 6200 Lookout Road, Boulder, CO 80301

Phone: 720 647 8519

Leadership

  • Sam Kintz, Co-founder, Chief Executive Officer, and Member of the Board of Directors
  • Joe Lyssikatos, Co-founder, Chief Scientific Officer
  • Anish Patel, Co-founder and Chief Operating Officer
  • Helen Collins, Chief Medical Officer
  • Ben Hohl, Chief Financial Officer and Head of Corporate Development
  • Galya Blachman, Chief Legal Officer and Head of Business Development
  • Rich A. Heyman, Chairman of the Board of Directors
  • Rishi Gupta, Member of the Board of Directors
  • Andy Phillips, Member of the Board of Directors
  • Mika Kakefuda Derynck, Member of the Board of Directors
  • Jake Bauer, Member of the Board of Directors
  • Rahul Ballal, Member of the Board of Directors
  • Lori Kunkel, Member of the Board of Directors
  • Brian Druker, Scientific Advisor
  • Kevin Koch, Scientific Advisor

Last updated: 2024-12-31

Candel Therapeutics, Inc.

Candel Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

CAN-2409, CAN-3110

Candel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer patients, with products like CAN-2409 and CAN-3110 in various clinical trial phases.

Tags: biopharmaceutical, cancer treatment, clinical trials, immunotherapies

Symbol: CADL

Recent Price: $7.95

Industry: Biotechnology

CEO: Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.

Sector: Healthcare

Employees: 42

Address: 117 Kendrick Street, Needham, MA 02494

Phone: 617 916 5445

Last updated: 2024-12-31

Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

ELI-002

Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for cancer and other diseases, with its lead product ELI-002 targeting KRAS-driven cancers.

Tags: Biotechnology, Cancer Treatment, Clinical-stage, Immunotherapy, Vaccines

Symbol: ELTX

Recent Price: $5.00

Industry: Biotechnology

CEO: Mr. Robert T. Connelly

Sector: Healthcare

Employees: 32

Address: 451 D Street, Boston, MA 02210

Phone: 857-209-0050

Last updated: 2024-12-31

ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

ORIC-533, ORIC-944, ORIC-114

ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.

Tags: ORIC-114, ORIC-533, ORIC-944, biopharmaceutical, cancer treatment, clinical-stage

Symbol: ORIC

Recent Price: $8.17

Industry: Biotechnology

CEO: Dr. Jacob M. Chacko M.B.A., M.D.

Sector: Healthcare

Employees: 107

Address: 240 East Grand Avenue, South San Francisco, CA 94080

Phone: 650 388 5600

Last updated: 2024-12-31

Veru Inc.

Veru Inc. logo
Market Cap: Low
Employees: Low

FC2 female condom

Veru Inc. is an oncology biopharmaceutical company focused on developing medicines for cancer management. The company offers commercial products and has several development drug candidates in clinical trials.

Tags: FC2 female condom, biopharmaceutical, cancer treatment, clinical trials, oncology

Symbol: VERU

Recent Price: $0.64

Industry: Biotechnology

CEO: Dr. Mitchell S. Steiner F.A.C.S., M.D.

Sector: Healthcare

Employees: 189

Address: 48 NW 25th Street, Miami, FL 33127

Phone: 305 509 6897

Last updated: 2024-12-31

Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ANEB-001

Anebulo Pharmaceuticals is a clinical-stage biotechnology company focused on developing and commercializing treatments for acute cannabinoid intoxication and substance addiction, including their lead product candidate ANEB-001.

Tags: ANEB-001, biotechnology, cannabinoid intoxication, clinical-stage, substance addiction

Symbol: ANEB

Recent Price: $1.64

Industry: Biotechnology

CEO: Mr. Richard Anthony Cunningham

Sector: Healthcare

Employees: 2

Address: 1415 Ranch Road 620 South, Lakeway, TX 78734

Phone: 512 598 0931

Last updated: 2024-12-31

Artelo Biosciences, Inc.

Artelo Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

ART27.13, ART12.11, ART26.12

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing treatments that modulate the endocannabinoid system, with a pipeline including treatments for cancer-related anorexia, inflammatory bowel disease, PTSD, prostate and breast cancer.

Tags: PTSD, biopharmaceutical, cancer treatment, clinical trial, endocannabinoid system, research collaboration, synthetic cannabidiol

Symbol: ARTL

Recent Price: $1.05

Industry: Biotechnology

CEO: Mr. Gregory D. Gorgas M.B.A.

Sector: Healthcare

Employees: 5

Address: 505 Lomas Santa Fe, Solana Beach, CA 92075

Phone: 858 925 7049

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Clever Leaves Holdings Inc.

Clever Leaves Holdings Inc. logo
Market Cap: Lowest
Employees: Low

cannabinoid and non-cannabinoid products

Clever Leaves Holdings Inc. is a cannabis company that operates in Cannabinoid and Non-Cannabinoid segments, focusing on international distribution of cannabinoid products and selling natural remedies and supplements in the United States.

Tags: Cannabinoid, Cannabis, Non-Cannabinoid, Nutraceuticals, Wellness

Symbol: CLVR

Recent Price: $0.03

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Andres Fajardo

Sector: Healthcare

Employees: 296

Address: 6501 Congress Avenue, Boca Raton, FL 33487

Phone: 561 634 7430

Last updated: 2024-12-31

Caribou Biosciences, Inc.

Caribou Biosciences, Inc. logo
Market Cap: Low
Employees: Low

CB-010, CB-011, CB-012, CB-020

Caribou Biosciences is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for treating hematologic malignancies and solid tumors, with several product candidates in clinical trials.

Tags: CAR-NK, CAR-T, biopharmaceutical, cell therapies, clinical-stage, genome-edited therapies, hematologic malignancies, solid tumors

Symbol: CRBU

Recent Price: $1.61

Industry: Biotechnology

CEO: Dr. Rachel E. Haurwitz Ph.D.

Sector: Healthcare

Employees: 158

Address: 2929 7th Street, Berkeley, CA 94710

Phone: 510 982 6030

Last updated: 2024-12-31

Curis, Inc.

Curis, Inc. logo
Market Cap: Lowest
Employees: Lowest

Emavusertib

Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.

Tags: biotechnology, cancer treatment, clinical trials, drug development, oncology

Symbol: CRIS

Recent Price: $3.14

Industry: Biotechnology

CEO: Mr. James E. Dentzer

Sector: Healthcare

Employees: 49

Address: Building C, Lexington, MA 02421

Phone: 617 503 6500

Leadership

  • Martyn D. Greenacre, Chair of the Board
  • John Hohneker, M.D., Director
  • Kenneth I. Kaitin, Ph.D., Director
  • Anne E. Borgman, M.D., Director
  • Marc Rubin, M.D., Director
  • James Dentzer, Chief Executive Officer and Director

Last updated: 2024-12-31

Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

PF614, PF614-MPAR, PF329

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company focused on developing prescription drugs for severe pain relief and opioid overdose protection using proprietary abuse-resistant technologies.

Tags: clinical trials, opioid, overdose protection, pain relief, pharmaceutical

Symbol: ENSC

Recent Price: $8.62

Industry: Biotechnology

CEO: Dr. D. Lynn Kirkpatrick Ph.D.

Sector: Healthcare

Employees: 7

Address: 7946 Ivanhoe Avenue, La Jolla, CA 92037

Phone: 858 263 4196

Last updated: 2024-12-31

Enveric Biosciences, Inc.

Enveric Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

Cannabinoid Medicines

Enveric Biosciences, Inc. is a pharmaceutical company focused on developing cannabinoid medicines for cancer care, including treatments for osteoarthritis, cancer-related distress, mental health, and topical skin applications.

Tags: biotechnology, cancer care, cannabinoid medicines, mental health, pharmaceuticals

Symbol: ENVB

Recent Price: $0.33

Industry: Biotechnology

CEO: Dr. Joseph Edward Tucker Ph.D.

Sector: Healthcare

Employees: 7

Address: 4851 Tamiami Trail North, Naples, FL 34103

Phone: 239 302 1707

Last updated: 2024-12-31

MEI Pharma, Inc.

MEI Pharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

Zandelisib

MEI Pharma, Inc. is a late-stage pharmaceutical company focused on developing and commercializing therapies for cancer treatment, including Zandelisib and Voruciclib.

Tags: Voruciclib, Zandelisib, cancer therapy, clinical trials, oncology, pharmaceutical

Symbol: MEIP

Recent Price: $2.45

Industry: Biotechnology

CEO: Mr. Justin J. File

Sector: Healthcare

Employees: 28

Address: 11455 El Camino Real, San Diego, CA 92130

Phone: 858 369 7100

Last updated: 2024-12-31

TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

therapeutics for cancer

TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.

Tags: TJ004309, TRC102, YH001, biopharmaceutical, cancer therapeutics, clinical trials, envafolimab

Symbol: TCON

Recent Price: $0.03

Industry: Biotechnology

CEO: Mr. Craig R. Jalbert CIRA

Sector: Healthcare

Employees: 17

Address: 4350 La Jolla Village Drive, San Diego, CA 92122

Phone: 858 550 0780

Last updated: 2024-12-31

Verve Therapeutics, Inc.

Verve Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

VERVE-101

Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.

Tags: VERVE-101, biotechnology, cardiovascular diseases, gene editing, genetic medicines

Symbol: VERV

Recent Price: $5.54

Industry: Biotechnology

CEO: Dr. Sekar Kathiresan M.D.

Sector: Healthcare

Employees: 255

Address: 500 Technology Square, Cambridge, MA 02139

Phone: 617 603 0070

Leadership

  • Andrew Ashe, President, Chief Operating Officer and General Counsel
  • Victoria Bartlett, Vice President, Program and Alliance Management
  • Dan Balian, Associate Director, Supply Chain Management
  • Allen Barrett, Director, Corporate Counsel

Last updated: 2024-12-31

Arcus Biosciences, Inc.

Arcus Biosciences, Inc. logo
Market Cap: High
Employees: Medium

Cancer Therapies

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing and commercializing cancer therapies, with a pipeline including products like Etrumadenant, Zimberelimab, and Domvanalimab among others.

Tags: biopharmaceutical, cancer therapies, clinical trials, oncology

Symbol: RCUS

Recent Price: $14.91

Industry: Biotechnology

CEO: Dr. Terry J. Rosen Ph.D.

Sector: Healthcare

Employees: 577

Address: 3928 Point Eden Way, Hayward, CA 94545

Phone: 510 694 6200

Last updated: 2024-12-31

Exelixis, Inc.

Exelixis, Inc. logo
Market Cap: Highest
Employees: Medium

CABOMETYX, COMETRIQ, COTELLIC, MINNEBRO

Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes new medicines to treat cancers, primarily in the United States. Its products include CABOMETYX, COMETRIQ, COTELLIC, and MINNEBRO.

Tags: biotechnology, cancer treatment, oncology, pharmaceuticals

Symbol: EXEL

Recent Price: $33.70

Industry: Biotechnology

CEO: Dr. Michael M. Morrissey Ph.D.

Sector: Healthcare

Employees: 1310

Address: 1851 Harbor Bay Parkway, Alameda, CA 94502

Phone: 650 837 7000

Last updated: 2024-12-31

Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc. logo
Market Cap: Low
Employees: Low

VTX958

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates for the treatment of inflammatory diseases and autoimmune disorders. Key products include VTX958 for immune-mediated diseases, VTX002 for ulcerative colitis, and VTX2735 for systemic inflammatory diseases.

Tags: VTX002, VTX2735, VTX958, autoimmune disorders, biopharmaceutical, clinical trials, inflammatory diseases, small molecule

Symbol: VTYX

Recent Price: $2.23

Industry: Biotechnology

CEO: Dr. Raju S. Mohan Ph.D.

Sector: Healthcare

Employees: 73

Address: 662 Encinitas Boulevard, Encinitas, CA 92024

Phone: 760 593 4832

Last updated: 2024-12-31